Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Cellular and Molecular Life Sciences : CMLS|November 16, 2018
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcomaIlaria Buondonno, Elena Gazzano, Elisa Tavanti, et al.
International Journal of Cancer|May 18, 2010
Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumorsJosé Antonio López-Guerrero, Isidro Machado, Katia Scotlandi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcomaKatia Scotlandi, Maria C Manara, Claudia M Hattinger, et al.
Frontiers in Pharmacology|February 11, 2020
Bioassay-Guided Isolation of Nigracin, Responsible for the Tissue Repair Properties of <i>Drypetes Klainei</i> Stem BarkGianluca Sferrazza, Marco Corti, Federica Andreola, et al.
European Journal of Cell Biology|October 30, 2003
Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniquesClaudia M Hattinger, Gemma Reverter-Branchat, Daniel Remondini, et al.
International Journal of Radiation Biology|July 29, 2008
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2Elisa Zuffa, Manuela Mancini, Gianluca Brusa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcomaI Scionti, F Michelacci, M Pasello, et al.
International Journal of Oncology|November 8, 2006
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocolMassimo Serra, Michela Pasello, Maria Cristina Manara, et al.
Molecular Biosystems|November 10, 2011
Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell linesAndrea Sau, Giuseppe Filomeni, Silvia Pezzola, et al.
International Journal of Molecular Sciences|April 23, 2022
Modulation of Amyloid β-Induced Microglia Activation and Neuronal Cell Death by Curcumin and AnaloguesErsilia De Lorenzi, Davide Franceschini, Cecilia Contardi, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Cellular and Molecular Life Sciences : CMLS|November 16, 2018
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcomaIlaria Buondonno, Elena Gazzano, Elisa Tavanti, et al.
International Journal of Cancer|May 18, 2010
Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumorsJosé Antonio López-Guerrero, Isidro Machado, Katia Scotlandi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcomaKatia Scotlandi, Maria C Manara, Claudia M Hattinger, et al.
Frontiers in Pharmacology|February 11, 2020
Bioassay-Guided Isolation of Nigracin, Responsible for the Tissue Repair Properties of <i>Drypetes Klainei</i> Stem BarkGianluca Sferrazza, Marco Corti, Federica Andreola, et al.
European Journal of Cell Biology|October 30, 2003
Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniquesClaudia M Hattinger, Gemma Reverter-Branchat, Daniel Remondini, et al.
International Journal of Radiation Biology|July 29, 2008
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2Elisa Zuffa, Manuela Mancini, Gianluca Brusa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcomaI Scionti, F Michelacci, M Pasello, et al.
International Journal of Oncology|November 8, 2006
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocolMassimo Serra, Michela Pasello, Maria Cristina Manara, et al.
Molecular Biosystems|November 10, 2011
Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell linesAndrea Sau, Giuseppe Filomeni, Silvia Pezzola, et al.
International Journal of Molecular Sciences|April 23, 2022
Modulation of Amyloid β-Induced Microglia Activation and Neuronal Cell Death by Curcumin and AnaloguesErsilia De Lorenzi, Davide Franceschini, Cecilia Contardi, et al.
Pageof 16